FindTrial
Sign In

Role of Glycocalyx Degradation in the incidence and severity of preeclampsia

Role of Glycocalyx Degradation in preeclampsia and severity of disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200062783
Enrollment
Unknown
Registered
2022-08-18
Start date
2022-08-15
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preeclampsia

Interventions

Preeclampsia:no intervention
Normal pregnant women:no intervention

Sponsors

Northwest Women and Children’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Preeclampsia and Normal pregnant women; 2. Singleton pregnancy; 3. Aged>= 18 years.

Exclusion criteria

Exclusion criteria: 1. Atherosclerosis; 2. Severe infection; 3. Various types of shock; 4. Diabetes mellitus(Gestational diabetes mellitus and Prepregnancy diabetes).

Design outcomes

Primary

MeasureTime frame
syndecan-1;hyaluronan,HA;heparan sulfate;—

Secondary

MeasureTime frame
coagulation indicator(PLT?PT?APTT);metabolic indicator(blood glucose?triglyceride?cholesterol);—

Countries

China

Contacts

Public ContactYanxiang Lyu

Northwest Women and Children’s Hospital

lvyanxiang8302@163.com+86 15332378220

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026